Search research articles
Contact Us
Filters
Showing results (111-120 of 290) with videos related to
Page
of 29
Sort By:
European Heart Journal
|
April 1, 1987
Ventricular tachycardia as a complication of annular subvalvular ventricular aneurysm in a Caucasian woman
R Geukens, F Van de Werf, H Ector, et al.
Lancet (London, England)
|
October 21, 1989
Bolus alteplase
M Verstraete, F van de Werf, B Tranchesi, et al.
Acta Cardiologica
|
January 1, 1988
Intravenous streptokinase during acute myocardial infarction. A prospective open study
F Stammen, F Van de Werf, J Vanhaecke, et al.
Circulation
|
November 1, 1986
Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction
F Van de Werf, J Vanhaecke, H de Geest, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1985
Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans
M Verstraete, H Bounameaux, F de Cock, et al.
The Journal of Clinical Investigation
|
May 1, 1984
The genesis of the third and fourth heart sounds. A pressure-flow study in dogs
F Van de Werf, J Minten, P Carmeliet, et al.
Acta Cardiologica
|
January 1, 1986
Aortic and mitral valve replacement in osteogenesis imperfecta. Report of a case
D Koentges, F van de Werf, J Stalpaert, et al.
The American Journal of Cardiology
|
August 1, 1993
On-line quantification of left ventricular function by automatic boundary detection and ultrasonic backscatter imaging
M C Herregods, J Vermylen, B Bynens, et al.
Circulation
|
October 15, 1995
Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up
A Maes, F Van de Werf, J Nuyts, et al.
Journal of the American College of Cardiology
|
February 1, 1993
Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: variation by country beyond predictive profile. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial
G I Barbash, M Modan, U Goldbourt, et al.
Page
of 29
Search research articles
Search
Showing results (111-120 of 290) with videos related to
Sort By:
Page
of 29
European Heart Journal
|
April 1, 1987
Ventricular tachycardia as a complication of annular subvalvular ventricular aneurysm in a Caucasian woman
R Geukens, F Van de Werf, H Ector, et al.
Lancet (London, England)
|
October 21, 1989
Bolus alteplase
M Verstraete, F van de Werf, B Tranchesi, et al.
Acta Cardiologica
|
January 1, 1988
Intravenous streptokinase during acute myocardial infarction. A prospective open study
F Stammen, F Van de Werf, J Vanhaecke, et al.
Circulation
|
November 1, 1986
Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction
F Van de Werf, J Vanhaecke, H de Geest, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1985
Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans
M Verstraete, H Bounameaux, F de Cock, et al.
The Journal of Clinical Investigation
|
May 1, 1984
The genesis of the third and fourth heart sounds. A pressure-flow study in dogs
F Van de Werf, J Minten, P Carmeliet, et al.
Acta Cardiologica
|
January 1, 1986
Aortic and mitral valve replacement in osteogenesis imperfecta. Report of a case
D Koentges, F van de Werf, J Stalpaert, et al.
The American Journal of Cardiology
|
August 1, 1993
On-line quantification of left ventricular function by automatic boundary detection and ultrasonic backscatter imaging
M C Herregods, J Vermylen, B Bynens, et al.
Circulation
|
October 15, 1995
Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up
A Maes, F Van de Werf, J Nuyts, et al.
Journal of the American College of Cardiology
|
February 1, 1993
Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: variation by country beyond predictive profile. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial
G I Barbash, M Modan, U Goldbourt, et al.
Page
of 29